Terms: = Leukemia AND MED12, Q93074, TRAP230, TNRC11, OKS, KIAA0192, HOPA, FGS1, CAGH45, ARC240, 9968 AND Treatment
5 results:
1. Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia-variant.
Locher M; Jukic E; Bohn JP; Untergasser G; Steurer M; Cramer CA; Schwendinger S; Vogi V; Verdorfer I; Witsch-Baumgartner M; Nachbaur D; Gunsilius E; Wolf D; Zschocke J; Steiner N
Genes Chromosomes Cancer; 2021 Apr; 60(4):287-292. PubMed ID: 33277788
[TBL] [Abstract] [Full Text] [Related]
2. Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib.
Machnicki MM; Górniak P; Pępek M; Szymczyk A; Iskierka-Jażdżewska E; Steckiewicz P; Bluszcz A; Rydzanicz M; Hus M; Płoski R; Makuch-Łasica H; Nowak G; Juszczyński P; Jamroziak K; Stokłosa T; Puła B
Eur J Haematol; 2021 Mar; 106(3):320-326. PubMed ID: 33190294
[TBL] [Abstract] [Full Text] [Related]
3. Initial steps in reconstruction of the human ovary: survival of pre-antral stage follicles in a decellularized human ovarian scaffold.
Pors SE; Ramløse M; Nikiforov D; Lundsgaard K; Cheng J; Andersen CY; Kristensen SG
Hum Reprod; 2019 Aug; 34(8):1523-1535. PubMed ID: 31286144
[TBL] [Abstract] [Full Text] [Related]
4. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
[TBL] [Abstract] [Full Text] [Related]
5. Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation.
Rubenstein M; Hollowell CM; Guinan P
In Vivo; 2015; 29(6):687-93. PubMed ID: 26546525
[TBL] [Abstract] [Full Text] [Related]
